Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin
PHASE3
Primary Objective:
To demonstrate the reduction of low-density lipoprotein...
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
PHASE3
Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.
PHASE3
To evaluate the efficacy and safety of diazepam in the management of refrac...
Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan
PHASE3
Primary Objective:
To demonstrate the reduction of low-density lipoprotein...